ATE500226T1 - Aripiprazolhemifumarat und verfahren zu dessen herstellung - Google Patents

Aripiprazolhemifumarat und verfahren zu dessen herstellung

Info

Publication number
ATE500226T1
ATE500226T1 AT07818336T AT07818336T ATE500226T1 AT E500226 T1 ATE500226 T1 AT E500226T1 AT 07818336 T AT07818336 T AT 07818336T AT 07818336 T AT07818336 T AT 07818336T AT E500226 T1 ATE500226 T1 AT E500226T1
Authority
AT
Austria
Prior art keywords
production
aripiprazole hemifumarate
hemifumarate
aripiprazole
crystalline
Prior art date
Application number
AT07818336T
Other languages
English (en)
Inventor
Marjo Merslavic
Urska Gojak
Matej Smrkolj
Sergeja Bombek
Marko Stefanic
Anamarija Vajs
Vesna Kroselj
Original Assignee
Krka Tovarna Zdravil D D Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200600219A external-priority patent/SI22381A/sl
Priority claimed from SI200700135A external-priority patent/SI22544A/sl
Application filed by Krka Tovarna Zdravil D D Novo Mesto filed Critical Krka Tovarna Zdravil D D Novo Mesto
Application granted granted Critical
Publication of ATE500226T1 publication Critical patent/ATE500226T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07818336T 2006-09-22 2007-09-21 Aripiprazolhemifumarat und verfahren zu dessen herstellung ATE500226T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200600219A SI22381A (sl) 2006-09-22 2006-09-22 Aripiprazol hemifumarat, njegova kristalna oblikain postopki za njegovo pripravo
SI200700135A SI22544A (sl) 2007-06-08 2007-06-08 Aripiprazol hemifumarat, njegova kristalna oblikain postopki za njegovo pripravo
PCT/EP2007/008247 WO2008034628A1 (en) 2006-09-22 2007-09-21 Aripiprazole hemifumarate and process for its preparation

Publications (1)

Publication Number Publication Date
ATE500226T1 true ATE500226T1 (de) 2011-03-15

Family

ID=38962941

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07818336T ATE500226T1 (de) 2006-09-22 2007-09-21 Aripiprazolhemifumarat und verfahren zu dessen herstellung

Country Status (7)

Country Link
EP (1) EP2081904B1 (de)
AT (1) ATE500226T1 (de)
DE (1) DE602007012924D1 (de)
EA (1) EA016840B1 (de)
SI (1) SI2081904T1 (de)
UA (1) UA94624C2 (de)
WO (1) WO2008034628A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2533050B3 (de) 2006-05-16 2015-06-24 Amicus Therapeutics, Inc. Behandlungsoptionen für Morbus Fabry
EP2233471A1 (de) 2009-02-06 2010-09-29 Adamed Sp. z o.o. Salz aus 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-chinolinon mit 5-sulfosalizyklischer säure und herstellungsverfahren
CA2773003A1 (en) * 2009-09-15 2011-03-24 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole
WO2013100878A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
EP3065700A1 (de) * 2013-11-07 2016-09-14 Synthon B.V. Im mund zerfallende pharmazeutische zusammensetzungen mit aripiprazol
CA3031249A1 (en) 2016-07-19 2018-01-25 Amicus Therapeutics, Inc. Treatment of fabry disease in ert-naive and ert-experienced patients
JP2022546995A (ja) * 2019-08-28 2022-11-10 デルポー・インコーポレイテッド 小分子治療剤化合物のための組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
US20060223820A1 (en) * 2006-03-21 2006-10-05 Chemagis Ltd. Crystalline aripiprazole salts and processes for preparation and purification thereof

Also Published As

Publication number Publication date
DE602007012924D1 (de) 2011-04-14
WO2008034628A1 (en) 2008-03-27
EA016840B1 (ru) 2012-07-30
UA94624C2 (uk) 2011-05-25
EA200900463A1 (ru) 2009-06-30
EP2081904A1 (de) 2009-07-29
EP2081904B1 (de) 2011-03-02
SI2081904T1 (sl) 2011-05-31

Similar Documents

Publication Publication Date Title
IL193340A0 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
MX343620B (es) Forma polimorfica de clorhidrato de pridopidina.
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
SG138588A1 (en) New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
ATE500226T1 (de) Aripiprazolhemifumarat und verfahren zu dessen herstellung
AP2011005935A0 (en) New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them.
MX2011012122A (es) Derivados de tiofeno.
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
IL188069A0 (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
ATE536864T1 (de) Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung
EP2666773A8 (de) Organische aminsalze aus azilsartan, herstellungsverfahren dafür und ihre verwendung
IL218525A (en) Compounds 2,1 - Dihydro - 2 - Oxoquinoline Receptor Legendants 5 - 4ht Process for Preparing, Containing and Using Medical Preparations
WO2011009533A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10) -dien-11-ethinylphenyl-derivate, verfahren zu deren herstellung und deren verwendung zur behandlung von krankheiten
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2008034912A3 (en) Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
MX2010003056A (es) Polimorfos de valomaciclovir.
ATE466863T1 (de) Neue aminopyrrolo-ä1,2-aü-indol- und aminopyridazino-ä1,6-aü-indol-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen damit
SG138589A1 (en) New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL209944A (en) Phenyl-Alkyl Paprazine Compounds, Process for Preparation, Pharmaceutical Composition and Drug Containing them
MX2010006218A (es) Compuestos organicos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties